argenx

Argenx is a global immunology company committed to improving the lives of patients suffering from rare autoimmune diseases. They are driven by a culture of co-creation, collaborating with pioneering researchers and academic partners to engineer life-changing immunology solutions. Argenx's focus on antibody engineering, specifically targeting the neonatal Fc receptor (FcRn), has yielded a rich pipeline of differentiated assets, including VYVGART, their first-in-class FcRn blocker approved for the treatment of generalized myasthenia gravis.

Argenx is expanding its reach to treat more patients across a range of severe autoimmune diseases. They are also investing in a pipeline of antibody candidates and scaling their operations to ensure innovation remains central to their mission. Their commitment to ESG principles is embedded in their core strategy, ensuring a sustainable business that delivers value today while shaping a better future for patients, employees, and communities.

argenx offers a variety of flexible work options, including remote work, part-time positions, and flexible schedules, to suit individual employee needs. The company prioritizes employee wellbeing and recognizes the importance of work-life balance, as evident in their job postings that highlight remote opportunities and flexible scheduling.

Argenx offers a comprehensive benefits package to its employees, designed to support their well-being and financial security. This includes medical, dental, and vision insurance, life insurance, disability coverage, and a 401(k) retirement savings plan with a company match. Employees also have access to paid time off, including vacation, sick leave, and holidays, as well as parental leave.

argenx is a global immunology biotech company committed to improving the lives of patients by engineering life-changing immunology solutions through the science of co-creation. They focus on developing first-in-class product candidates, particularly those targeting the neonatal Fc receptor (FcRn), with a strong emphasis on collaboration with academic partners to translate immunology breakthroughs into medicines.

argenx promotes a culture of collaboration, innovation, and excellence. They value co-creation, believing that bringing together diverse perspectives and expertise leads to the best outcomes. They encourage employees to take ownership and be empowered to make decisions that drive the company forward. Humility is also a key pillar, recognizing that mistakes are opportunities for growth and learning. This collaborative and innovative environment aims to foster a sense of belonging and shared purpose, ultimately enabling argenx to achieve its mission of improving the lives of patients.

argenx embraces diversity, equity, and inclusion as core values, fostering a welcoming and inclusive environment for all employees. They actively promote equal opportunities in employment and strive to create a workplace where everyone feels valued, respected, and empowered to contribute their unique perspectives and talents. Their commitment to ESG extends beyond just compliance, aiming to measure progress and shape a sustainable business that benefits patients, employees, collaborators, and the global community.